Critical Care Management of Lung Fibrosis, Review Article

Abstract

Pulmonary fibrosis or lung fibrosis have been one of the major complications associated with the lungs that lead to deprived quality of life and increased suffering in individuals who stop It leads an individual towards inability to involve in daily activities as well as sustain complications such as severe cuffs and shortness of breath which often leads to life-threatening condition if proper treatment and management procedures are not incorporated. It has also been found that due to the COVID-19 pandemic, the risk of sustaining pulmonary fibrosis in patients has increased which has led to increased complications and deprived health. Focusing on this evidence, the following research aims on evaluating critical care management and treatment procedures identified and acknowledged within the healthcare setting against pulmonary fibrosis or lung fibrosis. Critical care management must focus on limiting the progression of the condition, ensuring better lung functioning and health as well as improving quality of life. Concentrating on the rising issue, the following research study conducted a literature review using evidence from 5 selected articles and journals. The evidence obtained from the articles highlights that anti-fibrotic therapy such as Pirfenidone, pulmonary rehabilitation, and physical activity sustains the potential role of managing and enhancing health and quality of life in suffering patients. Apart from these identified management procedures, there is a vast range of strategies that can be incorporated into daily life by the patients to sustain better recovery from the condition and lead a healthy life with minimal risk of progression and prognosis of the condition.